Biblio
“A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1381-1392, 2020.
, “Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.”, J Alzheimers Dis, vol. 78, no. 1, pp. 321-334, 2020.
, “Comparative Cognitive Effects of Choreographed Exercise and Multimodal Physical Therapy in Older Adults with Amnestic Mild Cognitive Impairment: Randomized Clinical Trial.”, J Alzheimers Dis, vol. 73, no. 2, pp. 769-783, 2020.
, “Computational Modeling of Catecholamines Dysfunction in Alzheimer's Disease at Pre-Plaque Stage.”, J Alzheimers Dis, vol. 77, no. 1, pp. 275-290, 2020.
, “Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 75, no. 2, pp. 501-519, 2020.
, “The Contribution of Vascular Pathology Toward Cognitive Impairment in Older Individuals with Intermediate Braak Stage Tau Pathology.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1005-1015, 2020.
, “Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 127-138, 2020.
, “Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.”, J Alzheimers Dis, vol. 75, no. 2, pp. 437-450, 2020.
, “COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications.”, J Alzheimers Dis, vol. 77, no. 2, pp. 459-504, 2020.
, “Day-to-Day Home Blood Pressure Variability is Associated with Cerebral Small Vessel Disease Burden in a Memory Clinic Population.”, J Alzheimers Dis, vol. 74, no. 2, pp. 463-472, 2020.
, “Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.”, J Alzheimers Dis, vol. 78, no. 2, pp. 537-541, 2020.
, “Dementia Care in the Time of COVID-19 Pandemic.”, J Alzheimers Dis, vol. 76, no. 2, pp. 475-479, 2020.
, “Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain.”, J Alzheimers Dis, vol. 76, no. 1, pp. 33-40, 2020.
, “Dementia in the COVID-19 Period.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1071-1072, 2020.
, “Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy?”, J Alzheimers Dis, vol. 78, no. 1, pp. 405-412, 2020.
, “Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1417-1430, 2020.
, “Development of Classification Models for the Prediction of Alzheimer's Disease Utilizing Circulating Sex Hormone Ratios.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1029-1046, 2020.
, “Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1353-1368, 2020.
, “Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs.”, J Alzheimers Dis, vol. 74, no. 4, pp. 1013-1028, 2020.
, “Dyadic Group Exercises for Persons with Memory Deficits and Care Partners: Mixed-Method Findings from the Paired Preventing Loss of Independence through Exercise (PLIÉ) Randomized Trial.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1689-1706, 2020.
, “Effect of Mentally Challenging Occupations on Incident Dementia Differs Between African Americans and Non-Hispanic Whites.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1405-1416, 2020.
, “The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.”, J Alzheimers Dis, vol. 76, no. 1, pp. 41-47, 2020.
, “Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 75, no. 3, pp. 903-910, 2020.
, “Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1083-1102, 2020.
, “Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
,